Elżbieta Papuga-Szela

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia

Agnieszka Janion−Sadowska, Elżbieta Papuga-Szela, Robert Łukaszuk et al. · Journal of Cardiovascular Pharmacology · 2018 · 27 citations · Full text

Direct oral anticoagulants in the treatment of cerebral venous sinus thrombosis: a single institution’s experience

Gabriela Rusin, Ewa Wypasek, Elżbieta Papuga-Szela et al. · Neurologia i Neurochirurgia Polska · 2018 · 23 citations · Full text

Chronic Kidney Disease and Its Impact on a Prothrombotic State in Patients with Atrial Fibrillation

Paweł T. Matusik, Zbigniew Heleniak, Elżbieta Papuga-Szela et al. · Journal of Clinical Medicine · 2020 · 19 citations · Full text

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease Stage G4: A Single-Center Experience

Zbigniew Heleniak, Elżbieta Papuga-Szela, Krzysztof Plens et al. · Journal of Cardiovascular Pharmacology · 2020 · 15 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +19

Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study

Joanna Żuk, Elżbieta Papuga-Szela, Lech Zaręba et al. · International Journal of Hematology · 2020 · 13 citations · Full text

Thrombosis, Venous Thrombosis, Direct Oral Anticoagulants +11